|
AU2004235781A1
|
|
Lipid platinum complexes and methods of use thereof
|
|
CA2525952A1
|
|
Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
|
|
WO2004103382A1
|
|
Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex
|
|
WO2004105747A1
|
|
Combination chemotherapy comprising capecitabine and a liposomal platinum complex
|
|
EP1663153A1
|
|
Combination chemotherapy comprising a liposomal platinum complex
|
|
WO02066022A1
|
|
Retinoid hepatitis therapy
|
|
US2002076434A1
|
|
Liposomal retinoid therapy in hormone refractory prostate cancer
|
|
US2002127273A1
|
|
Liposomal nystatin treatment of fungal infection
|
|
AU4380201A
|
|
Antisense inhibitors of vascular endothelial growth factor (VEgF/VPF) expression
|
|
EP1307220A1
|
|
Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
|
|
US2002001615A1
|
|
Combined interferon alfa and lipsosmal-encapsulated all-trans retinoic acid, including preparation and use
|
|
AU9018898A
|
|
Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
|
|
US6288042B1
|
|
Anti-viral guanosine-rich tetrad forming oligonucleotides
|
|
AU6262598A
|
|
Anti-viral guanosine-rich tetrad forming oligonucleotides
|
|
US5994321A
|
|
Antiviral guanine analogs
|
|
EP0871643A1
|
|
Anti-viral guanosine-rich oligonucleotides
|
|
US5753262A
|
|
Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
|
|
US5614503A
|
|
Amphipathic nucleic acid transporter
|
|
US5567604A
|
|
Anti-viral guanosine-rich oligonucleotides
|
|
US5587458A
|
|
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
